Purpose Hereditary angioedema (HAE) is a rare disease caused by a C1 inhibitor (C1-INH)
deficit. Clinically, HAE is manifested by repeated episodes of localized subcutaneous or …

Abstract Purpose of Review Hereditary angioedema (HAE) is a disorder affecting bradykinin
regulation presenting as recurrent cutaneous or mucosal swelling. Treatment options …

OBJECTIVE: The course of hereditary angioedema (HAE) and the efficacy and safety of
human C1-INH concentrate were appraised during pregnancy and the postpartum period, in …

Methods Retrospective review using a purpose-designed questionnaire of 61 C1INH-HAE
patients from 5 hospitals specialized in the management of HAE in Spain. The outcomes …

Backgroud Hereditary angioedema (HAE) is a rare genetic disorder caused by a deficiency
of the plasma protein C1 inhibitor (C1-INH). HAE is characterised by the onset of …

Hereditary angioedema resulting from C1‐inhibitor deficiency (C1‐INH‐HAE) is a rare,
autosomal dominant disorder, characterized by recurrent attacks of edema formation. The …

Patients with hereditary angioedema (HAE) need a special concern during pregnancy.
Although, the disease has a relatively benign course during pregnancy, maternal mortality …

Consensus guidelines recommend plasma-derived C1 inhibitor (C1-INH) as first-line
treatment in pregnant women with hereditary angioedema (HAE). We conducted a …

BACKGROUND: There are a limited number of publications on the management of
gynecologic/obstetric events in female patients with hereditary angioedema caused by C1 …

Hereditary angioedema (HAE) is a rare disorder resulting from decreased functional levels
of C1-inhibitor (C1-INH), which manifests as periodic episodes of localized edema which …